My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Public release date: 29-Sep-2011 UCI study shows promise of metabolic therapy for autoimmune diseases A glucosamine-like dietary supplement suppresses the damaging autoimmune response seen in multiple sclerosis, according to a…
- They found that early-stage MS patients who had adequate levels of vitamin D had a 57% lower rate of new brain lesions, a 57% lower relapse rate, and a…
Contact: Colleen Hayes cehayes@wisc.edu 608-263-6387 University of Wisconsin-Madison Mouse studies reveal promising vitamin D-based treatment for MS MADISON -- A diagnosis of multiple sclerosis (MS) is a hard lot. Patients…
Contact: Colleen Hayes cehayes@wisc.edu 608-263-6387 University of Wisconsin-Madison Mouse studies reveal promising vitamin D-based treatment for MS MADISON -- A diagnosis of multiple sclerosis (MS) is a hard lot. Patients…
Re-post 34th HRR 2008 Contact: Tom Rickey tom_rickey@urmc.rochester.edu 585-275-7954 University of Rochester Medical Center Cholesterol-lowering drugs known as statins have a profound effect on an elite group of cells important…
Contact: Tom Vasich tmvasich@uci.edu 949-824-6455 University of California - Irvine UCI study shows promise of metabolic therapy for autoimmune diseases Irvine, Calif., Sept. 30, 2011 — A glucosamine-like dietary supplement…
You must be logged in to post a comment.